Cargando…
Application of botulinum toxin to reduce the saliva in patients with amyotrophic lateral sclerosis
Aim: To demonstrate the effect of local application of Botox® in patients with amyotrophic lateral sclerosis (ALS), following our 2002 institutional protocol of sialorrhea treatment. Study Design: Clinical prospective. Material and Method: Five patients with ALS assisted at Clinic of Otolaryngology...
Autor principal: | Manrique, Dayse |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441962/ https://www.ncbi.nlm.nih.gov/pubmed/16612515 http://dx.doi.org/10.1016/S1808-8694(15)31258-1 |
Ejemplares similares
-
Application of botulinum toxin to treat sialorrhea in amyotrophic lateral sclerosis patients: a literature review
por: de Oliveira, Ademar Francisco, et al.
Publicado: (2016) -
Botulinum Toxin Type A and Physiotherapy in Spasticity of the Lower Limbs Due to Amyotrophic Lateral Sclerosis
por: Marvulli, Riccardo, et al.
Publicado: (2019) -
Saliva and Saliva Extracellular Vesicles for Biomarker Candidate Identification—Assay Development and Pilot Study in Amyotrophic Lateral Sclerosis
por: Sjoqvist, Sebastian, et al.
Publicado: (2023) -
Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009) -
Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis
por: Beers, David R., et al.
Publicado: (2011)